Sithisat Chiamwongpaet
Biographic Data
| ID | 6059667 |
|---|---|
| NAME | Sithisat Chiamwongpaet |
| GIVEN NAMES | Sithisat |
| FAMILY NAME | Chiamwongpaet |
| SIGNATURE | CHIAMWONGPAET S |
| AFFILIATIONS | Bangkok Metropolitan Administration |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2015 |
| H-INDEX | 0 |
High Mortality Among Non–HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005–2012
Objectives. We examined the causes of hospitalization and death of people who inject drugs participating in the Bangkok Tenofovir Study, an HIV preexposure prophylaxis trial. Methods. The Bangkok Tenofovir Study was a randomized, double-blind, placebo-controlled trial conducted during 2005 to 2012 among 2413 people who inject drugs. We reviewed medical records to define the causes of hospitalization and death, examined participant characteristics…
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study)
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003
No prominent works on this page.
Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999–2003
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study)
High Mortality Among Non–HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005–2012
Objectives. We examined the causes of hospitalization and death of people who inject drugs participating in the Bangkok Tenofovir Study, an HIV preexposure prophylaxis trial. Methods. The Bangkok Tenofovir Study was a randomized, double-blind, placebo-controlled trial conducted during 2005 to 2012 among 2413 people who inject drugs. We reviewed medical records to define the causes of hospitalization and death, examined participant characteristics…
Alternative medicine (3 works) · HIV, Drug Use, Sexual Risk (3 works) · HIV/AIDS Research and Interventions (3 works) · Medicine (3 works) · Placebo (3 works) · Human immunodeficiency virus (HIV) (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Adverse effect (1 work) · Cause of death (1 work)